For drug and device companies, a product recall is bad. Dealing with multiple recalls at the same time is worse. Trying to manage either scenario without a plan is nightmare territory. That’s what ExpertRECALL wanted to illustrate during a mock recall held last month in Indianapolis. The company devoted a half-day of the Bio/Pharmaceutical and […]
A Purdue University startup thinks it has a solution for the challenge of getting soft tissue to bond with hard bone. BioRegeneration Technologies co-founders Darryl Dickerson and Eric Nauman say InMotion has the potential to be a one-time-only, permanent solution for joint pain and degeneration. InMotion is a porous scaffolding made of a nonbiodegradable, collagen-based […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
There’s a lot of money at stake when pharmaceutical companies are developing a drug with blockbuster potential. MedeoLinx Inc. wants to improve the odds. The Indianapolis bioanalytical CRO says its informaticians and medical scientists can accurately predict a drug’s potential and likely success in the approval process, said Dr. Jake Chen, company founder. Pharmaceutical companies […]
Diagnotes Inc. wants to make it easier for on-call doctors to get up to speed quickly with patients they may have never met. The Indianapolis startup is on the verge of launching a two-part strategy to enable on-call clinicians and physicians to provide care faster and to ensure the patient gets proper follow-up care. Diagnotes […]